FDA — authorised 31 October 1986
- Marketing authorisation holder: METHAPHARM
- Status: approved
🇺🇸 Provocholine in United States
FDA authorised Provocholine on 31 October 1986
Marketing authorisations
FDA — authorised 31 October 1986
- Application: NDA019193
- Marketing authorisation holder: METHAPHARM
- Local brand name: PROVOCHOLINE
- Indication: FOR SOLUTION — INHALATION
- Status: approved
Provocholine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in United States
Frequently asked questions
Is Provocholine approved in United States?
Yes. FDA authorised it on 31 October 1986; FDA authorised it on 31 October 1986.
Who is the marketing authorisation holder for Provocholine in United States?
METHAPHARM holds the US marketing authorisation.